These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 25463126)

  • 1. Role of lipoprotein-associated phospholipase A2 activity for the prediction of silent brain infarcts in women.
    Riba-Llena I; Penalba A; Pelegrí D; Vilar A; Jarca CI; Filomena J; Montaner J; Delgado P;
    Atherosclerosis; 2014 Dec; 237(2):811-5. PubMed ID: 25463126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.
    Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D
    Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal profile and prognostic value of Lp-PLA2 mass and activity in the acute stroke setting.
    Delgado P; Chacón P; Penalba A; Pelegrí D; Merino C; Ribó M; Rubiera M; Álvarez-Sabin J; Montaner J
    Atherosclerosis; 2012 Feb; 220(2):532-6. PubMed ID: 22153151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of lipoprotein-associated phospholipase A
    Han L; Zhong C; Bu X; Xu T; Wang A; Peng Y; Xu T; Wang J; Peng H; Li Q; Ju Z; Geng D; Zhang Y; He J;
    Atherosclerosis; 2017 Nov; 266():1-7. PubMed ID: 28934604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
    Persson M; Hedblad B; Nelson JJ; Berglund G
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association of lipoprotein-associated phospholipase activity A2 with cardiovascular risk factors].
    Acevedo M; Varleta P; Kramer V; Quiroga T; Prieto C; Parada J; Adasme M; Briones L; Navarrete C
    Rev Med Chil; 2013 Nov; 141(11):1382-8. PubMed ID: 24718463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein phospholipase A2 mass and activity are not associated with the diagnosis of acute brain ischemia.
    Tai W; Garcia M; Mlynash M; Kemp S; Albers GW; Olivot JM
    Cerebrovasc Dis; 2014; 38(5):324-7. PubMed ID: 25428761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum lipoprotein-associated phospholipase A2 predicts the formation of carotid artery plaque and its vulnerability in anterior circulation cerebral infarction.
    Yang Y; Xue T; Zhu J; Xu J; Hu X; Wang P; Kong T; Yan Y; Yang L; Xue S
    Clin Neurol Neurosurg; 2017 Sep; 160():40-45. PubMed ID: 28644968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advantages of the lipoprotein-associated phospholipase A2 activity assay.
    Donato LJ; Meeusen JW; Callanan H; Saenger AK; Jaffe AS
    Clin Biochem; 2016 Jan; 49(1-2):172-5. PubMed ID: 26365697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.
    Ueshima H; Kadowaki T; Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Sekikawa A; Kadota A; Kadowaki S; Nakamura Y; Miyagawa N; Okamura T; Kita Y; Takashima N; Kashiwagi A; Maegawa H; Horie M; Yamamoto T; Kimura T; Kita T;
    Atherosclerosis; 2016 Mar; 246():141-7. PubMed ID: 26775119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the lipoprotein-associated phospholipase A2 activity and the progression of subclinical atherosclerosis.
    Liu J; Wang W; Qi Y; Yong Q; Zhou G; Wang M; Sun J; Liu J; Jia Z; Zhao D
    J Atheroscler Thromb; 2014; 21(6):532-42. PubMed ID: 24492522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
    Kiechl S; Willeit J; Mayr M; Viehweider B; Oberhollenzer M; Kronenberg F; Wiedermann CJ; Oberthaler S; Xu Q; Witztum JL; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1788-95. PubMed ID: 17541022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipase A2 in patients with noncardioembolic ischemic stroke and severe inflammatory reaction.
    Cojocaru IM; Cojocaru M; Tănăsescu R; Iliescu I; Dumitrescu L; Burcin C; Gurban CV; Sfrijan F
    Rom J Intern Med; 2009; 47(1):61-5. PubMed ID: 19886071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
    Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
    Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Lipoprotein-associated Phospholipase A2 in Serum in Patients With Stage 3-5 Chronic Kidney Disease.
    Wang Y; Li SS; Na SP; Yu CY; Ji Y; Zhao SL; Xie RJ; Bao YS
    Am J Med Sci; 2016 Oct; 352(4):348-353. PubMed ID: 27776715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein-associated phospholipase A2 and coronary calcification. The Rotterdam Coronary Calcification Study.
    Kardys I; Oei HH; Hofman A; Oudkerk M; Witteman JC
    Atherosclerosis; 2007 Apr; 191(2):377-83. PubMed ID: 16678183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
    Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Chambless LE; Myerson M; Wu KK; Sharrett AR; Boerwinkle E
    Arch Intern Med; 2005 Nov; 165(21):2479-84. PubMed ID: 16314544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Lp-PLA2 in acute coronary syndrome: association with major adverse cardiac events in a community-based cohort.
    Li N; Li S; Yu C; Gu S
    Postgrad Med; 2010 Jul; 122(4):200-5. PubMed ID: 20675983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein-associated phospholipase A2 during the hyperacute stage of ischemic and hemorrhagic strokes.
    Rosso C; Rosenbaum D; Pires C; Cherfils C; Koujah N; Mestari F; Gillet E; Crozier S; Sahli-Amor M; Samson Y; Bonnefont-Rousselot D; Khani-Bittar R
    J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):e277-82. PubMed ID: 24513482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.